SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ERAS

Erasca, Inc.
NASDAQHealth Care

Latest close: 13.39 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 15, 2026Notice of sale · Form 144Erasca Foundation · Foundation · $122.4KOpen the filing ↗
  3. Sep 15, 2026Notice of sale · Form 144Erasca Foundation · Foundation · $133.1KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record33117 flagged findings
Reported transactions (Form 4)73since Nov 30, 2022 · and 4 other holdings
Corporate events (8-K)12since Nov 23, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-11share offering or dilution eventrecentOpen filing ↗
    “…of $ 15.5 million and offering costs of $ 519,000 . 12 ATM offerings In August 2022, the Company entered into an Open Market Sale…”
    +1 more passage from the same document
    • “…million, net of underwriting discounts and commissions and offering costs of $9.6 million. In August 2022, we entered into an Open…”
  • 2026-05-11merger or acquisition eventrecentOpen filing ↗
    “…State of Delaware on July 2, 2018, as Erasca, Inc., and is headquartered in San Diego, California. In September 2020, the Company…”
    +1 more passage from the same document
    • “…the Company established a wholly-owned Australian subsidiary, Erasca Australia Pty Ltd (Erasca Australia), in order to conduct…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 331)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 16, 268-K ↗Current report · A senior executive left or was appointed new
  • Notice of proposed sale · 2 Form 144 filings newshow all 2hide
  • Aug 24, 268-K ↗Current report · Other events
  • Aug 17, 26Form 144 ↗Notice of proposed sale
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Jonathan E. Lim · 10.4% · event on Jun 30, 26 · amendment
  • Aug 12, 26Form 4 ↗Insider transaction
  • Aug 12, 26Form 3 ↗Insider transaction
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Aug 10, 268-K ↗Current report · A senior executive left or was appointed
  • Jul 21, 26Form 144 ↗Notice of proposed sale
  • Jul 14, 268-K ↗Current report · Other events
  • Jul 14, 26424B5 ↗Securities offering
  • Jul 13, 26424B5 ↗Securities offering
  • Jul 13, 268-K ↗Current report · Other events
  • Jul 13, 26S-3ASR ↗Securities offering
  • Jul 1, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Jun 15, 26Form 144 ↗Notice of proposed sale

331 filings on record, the oldest from Jun 2, 21.

Listing the 25 most recent filings of the 331 on record.

8-Ks, explained

Stress1Structure7Governance4
  • Oct 16, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 10, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • May 16, 24StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Mar 28, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 10, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 9, 22StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Dec 9, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 27, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 23, 21StructureEntered a material agreement8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Jonathan E. Lim10.4%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • James N. Topper8.0%Mar 31, 25SCHEDULE 13G/A ↗17 co-filers on this document — the figure is the largest single stake, not their sum.
  • T. Rowe Price Investment Management, Inc.6.8%Mar 31, 26SCHEDULE 13G/A ↗2 earlier filings
  • Venrock Healthcare Capital Partners III, L.P.5.3%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • Frazier Life Sciences Public Fund, L.P.5.3%Jun 30, 25SCHEDULE 13G/A ↗17 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
  • RTW Investments, LP5.2%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Logos Global Management LP4.8%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Novartis Pharma AG4.4%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Paradigm BioCapital Advisors LP3.3%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Suvretta Capital Management, LLC1.1%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 15, Erasca Foundation filed notice of intent to sell up to $122K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+3 more recent notices

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Apr 1, 26Sell$1.3MEbun GarnerChief Legal Officer↗
  • Mar 4, 26Sell$301KShannon MorrisChief Medical Officer↗
  • Jan 7, 26Sell$671KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • May 21, 24Buy$182KAlexander W. Casdin↗
  • Dec 6, 23Buy$478KJonathan E LimChairman & CEO↗
  • Dec 6, 23Buy$18KValerie Denise Harding Start↗
  • Dec 5, 23Buy$1.2MJonathan E LimChairman & CEO↗
  • Dec 4, 23Buy$50KAlexander W. Casdin↗
  • Oct 5, 23Buy$2.0MJonathan E LimChairman & CEO↗
  • Jun 8, 23Buy$275KJonathan E LimChairman & CEO↗
  • Apr 10, 23Buy$55KAlexander W. Casdin↗
  • Mar 28, 23Buy$284KJonathan E LimChairman & CEO↗

There is 1 more transaction in this stretch.

Stock compensation, tax and giftsshow the 20 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Apr 1, 26Compensation$136KEbun GarnerChief Legal Officer↗
  • Mar 4, 26Compensation$34KShannon MorrisChief Medical Officer↗
  • Jan 7, 26Compensation$204KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Dec 15, 25Compensation$5KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Dec 15, 25Other$21KDavid M. ChackoCFO and CBO↗
  • May 23, 25Giftamount n/aPratik S Multani↗
  • May 23, 25Giftamount n/aPratik S Multani↗
  • Dec 13, 24Other$9KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Dec 13, 24Other$19KDavid M. ChackoCFO and CBO↗
  • Jun 14, 24Other$9KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Jun 14, 24Other$5KDavid M. ChackoCFO and CBO↗
  • Dec 15, 23Other$9KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Dec 15, 23Other$12KDavid M. ChackoCFO and CBO↗
  • Feb 1, 23Other$10KEbun GarnerGeneral Counsel & Corp. Sec.↗
  • Feb 1, 23Other$8Ebun GarnerGeneral Counsel & Corp. Sec.↗
  • Feb 1, 23Other$7KLin WeiChief Medical Officer↗
  • Feb 1, 23Other$8Lin WeiChief Medical Officer↗
  • Feb 1, 23Other$7KDavid M. ChackoChief Financial Officer↗
  • Feb 1, 23Other$8David M. ChackoChief Financial Officer↗
  • Nov 30, 22Giftamount n/aJonathan E LimChairman and CEO↗

The full record holds 33 transactions and goes back to Nov 30, 22.

Its sector and its market

Erasca, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Erasca, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Erasca, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
331 documents on file, from Jun 2, 2021 to Oct 16, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.